FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $721,975 | +444.1% | 340,554 | +1121.7% | 0.00% | – |
Q2 2023 | $132,690 | -16.5% | 27,876 | 0.0% | 0.00% | – |
Q1 2023 | $158,893 | -43.5% | 27,876 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $281,269 | -60.4% | 27,876 | -12.1% | 0.00% | -50.0% |
Q3 2022 | $711,000 | -9.5% | 31,706 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $786,000 | -35.8% | 31,706 | +0.4% | 0.00% | 0.0% |
Q1 2022 | $1,224,000 | -33.7% | 31,566 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $1,847,000 | -2.6% | 31,566 | -1.4% | 0.00% | -25.0% |
Q3 2021 | $1,897,000 | -31.3% | 32,013 | +0.6% | 0.00% | -20.0% |
Q2 2021 | $2,761,000 | +19.0% | 31,813 | +13.0% | 0.01% | 0.0% |
Q1 2021 | $2,321,000 | -7.3% | 28,151 | +2.2% | 0.01% | 0.0% |
Q4 2020 | $2,505,000 | +144.2% | 27,551 | +7.3% | 0.01% | +150.0% |
Q3 2020 | $1,026,000 | +20.8% | 25,671 | +3.7% | 0.00% | 0.0% |
Q2 2020 | $849,000 | +54.4% | 24,751 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $550,000 | +13.6% | 24,751 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $484,000 | +26.0% | 24,751 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $384,000 | -23.5% | 24,751 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $502,000 | +32.1% | 24,751 | +14.6% | 0.00% | 0.0% |
Q1 2019 | $380,000 | +37.2% | 21,601 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $277,000 | -6.1% | 21,601 | +19.1% | 0.00% | 0.0% |
Q3 2018 | $295,000 | +43.2% | 18,139 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $206,000 | – | 18,139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |